Cargando…

Potential Clinical Value of Pretreatment De Ritis Ratio as a Prognostic Biomarker for Renal Cell Carcinoma

BACKGROUND: We performed this study to explore the prognostic value of the pretreatment aspartate transaminase to alanine transaminase (De Ritis) ratio in patients with renal cell carcinoma (RCC). METHODS: PubMed, EMBASE, Web of Science, and Cochrane Library were searched to identify all studies. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jinze, Cao, Dehong, Peng, Lei, Meng, Chunyang, Xia, Zhongyou, Li, Yunxiang, Wei, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724044/ https://www.ncbi.nlm.nih.gov/pubmed/34993141 http://dx.doi.org/10.3389/fonc.2021.780906

Ejemplares similares

Prognostic value of pretreatment serum albumin−globulin ratio in urothelial carcinoma: A systematic review and meta-analysis
por: Xia, Zhongyou, et al.
Publicado: (2022)

Comparison of the Efficacy and Safety of Minimally Invasive Simple Prostatectomy and Endoscopic Enucleation of Prostate for Large Benign Prostatic Hyperplasia
por: Li, Jinze, et al.
Publicado: (2021)

Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis
por: Su, Shiqiang, et al.
Publicado: (2020)

Controlling Nutritional Status Score Before Receiving Treatment as a Prognostic Indicator for Patients With Urothelial Cancer: An Exploration Evaluation Methods
por: Peng, Lei, et al.
Publicado: (2021)

Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis
por: Keiner, Cathrine, et al.
Publicado: (2022)

Comparison of Perioperative Outcomes of Robot-Assisted vs. Laparoscopic Radical Nephrectomy: A Systematic Review and Meta-Analysis
por: Li, Jinze, et al.
Publicado: (2020)

Diagnostic Value of Telomerase Activity in Patients With Bladder Cancer: A Meta-Analysis of Diagnostic Test
por: Peng, Lei, et al.
Publicado: (2020)

Pretreatment Aspartate Aminotransferase-to-Alanine Aminotransferase (De Ritis) Ratio Predicts the Prognosis of Nonmetastatic Nasopharyngeal Carcinoma
por: Wu, Jiayuan, et al.
Publicado: (2019)

Comparison of Perioperative Outcomes of Robotic-Assisted vs Laparoscopic Adrenalectomy for Pheochromocytoma: A Meta-Analysis
por: Xia, Zhongyou, et al.
Publicado: (2021)

Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Development of a Nomogram in Breast Cancer Patients
por: Yin, Ying, et al.
Publicado: (2021)

Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
por: Janisch, Florian, et al.
Publicado: (2021)

The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy
por: Quhal, Fahad, et al.
Publicado: (2020)

Comparison of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Transperitoneal Laparoscopic Adrenalectomy for Adrenal Tumors: A Systematic Review and Meta-Analysis
por: Meng, Chunyang, et al.
Publicado: (2021)

Prognostic Value of Pretreatment Prognostic Nutritional Index in Patients With Renal Cell Carcinoma: A Meta-Analysis
por: Mao, Changqing, et al.
Publicado: (2021)

Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma
por: Meng, Meng, et al.
Publicado: (2021)

Prognostic nutritional index before surgical treatment may serve as a prognostic biomarker for patients with upper tract urothelial carcinoma: A systematic review and meta-analysis
por: Meng, Chunyang, et al.
Publicado: (2022)

The prognostic value of De Ritis (AST/ALT) ratio in patients after surgery for urothelial carcinoma: a systematic review and meta-analysis
por: Hu, Xu, et al.
Publicado: (2020)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy
por: Gao, Yiming, et al.
Publicado: (2022)

De-Ritis Ratio Is Associated with Mortality after Cardiac Arrest
por: Lu, Zhengri, et al.
Publicado: (2020)

Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients
por: Wu, Jiayuan, et al.
Publicado: (2019)

Serum albumin to globulin ratio prior to treatment as a potential non-invasive prognostic indicator for urological cancers
por: Xia, Zhongyou, et al.
Publicado: (2022)

Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis
por: Ni, Liwei, et al.
Publicado: (2019)

The De Ritis and Neutrophil-to-Lymphocyte Ratios May Aid in the Risk Assessment of Patients with Metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2018)

A High De Ritis Ratio is Associated with Mortality in Adult Trauma Patients
por: Tsai, Ching-Hua, et al.
Publicado: (2023)

Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet−to−Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta−analysis
por: Leng, Jiali, et al.
Publicado: (2022)

The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [(177)Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis
por: Ruhwedel, Tristan, et al.
Publicado: (2021)

Avanafil for the Treatment of men With Erectile Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Li, Jinze, et al.
Publicado: (2019)

Meta-analysis of the prognostic value of pretreatment serum ferritin in hepatobiliary and pancreas (HBP) cancers
por: Lin, Shuwen, et al.
Publicado: (2021)

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer
por: Fu, Jinming, et al.
Publicado: (2023)

Prognostic Role of Pretreatment C-Reactive Protein to Albumin Ratio in Urological Cancers: A Systematic Review and Meta-Analysis
por: Wu, Minhong, et al.
Publicado: (2022)

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Pediatric Parotid Cancer
por: Seng, Dongjie, et al.
Publicado: (2019)

The AST/ALT (De Ritis) Ratio Predicts Survival in Patients with Oral and Oropharyngeal Cancer
por: Knittelfelder, Olivia, et al.
Publicado: (2020)

The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients
por: Drácz, Bálint, et al.
Publicado: (2022)

Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis
por: Qiu, Ye, et al.
Publicado: (2021)

Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke
por: Ahmadabad, Mona Asghari, et al.
Publicado: (2022)

Association between Increased the De Ritis Quotient and Renal Azotaemia in Canine Babesiosis
por: Gójska-Zygner, Olga, et al.
Publicado: (2022)

Prognostic Value of the De Ritis Ratio for Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [(177)Lu]Lu-PSMA-617 Radioligand Therapy
por: Gaal, Sebastian, et al.
Publicado: (2023)

Prognostic Value of Pretreatment Controlling Nutritional Status Score for Patients With Pancreatic Cancer: A Meta-Analysis
por: Ma, Xiaofeng, et al.
Publicado: (2022)

The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study
por: Wang, Lianzi, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Chen, Xiuqiong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_skfa5b891v12odd7iu4jli8gtp